Our Product Development organization works around the world to identify the most promising projects with the greatest potential impact on patients. Once proof-of-concept has been established for an investigational medicine, it moves from Research and Early Development to Product Development, where it goes through rigorous clinical testing in order to determine and demonstrate the medicine’s potential benefit as a medicine.
Product Development determines which potential new medicines have the best prospects for development by testing the formulas against specific diseases in the clinic and then guiding chosen medicine candidates through the many precise phases of clinical testing. We conduct global clinical trials, analyze results, monitor safety, and work with regulatory authorities to provide differentiated medicines to patients.
Our primary disease focus areas are Oncology, Immunology and Infectious Diseases, Ophthalmology, and Neuroscience. We attract, develop, and retain top industry talent, with Development centers in Basel, Switzerland; South San Francisco, California; Welwyn, England; Mississauga, Canada; and Shanghai, China.